BRIEF-Valeant and Progenics announce the U.S. commercial launch of FDA-approved Relistor tablets

Tue Sep 6, 2016 5:18pm EDT
 
Email This Article |
Share This Article
  • Facebook
  • LinkedIn
  • Twitter
| Print This Article
[-] Text [+]

Sept 6 (Reuters) - Progenics Pharmaceuticals Inc

* Valeant and Progenics announce the U.S. commercial launch of FDA approved Relistor tablets Source text for Eikon: Further company coverage: